Press Releases

CAMBRIDGE, Mass., Jan 3, 2002 (BW HealthWire) -- Alkermes, Inc. (NASDAQ: ALKS) announced today that its new corporate presentation will be webcast live by JP Morgan H&Q on Tuesday, January 8, 2002 at 6:00pm ET (3:00pm PT). The webcast may be viewed live at http://php4.eventsdigital.com/events/jpmhq/healthcare2002/index.html and will remain archived for 60 days.

Richard Pops, Chief Executive Officer, of Alkermes, Inc., will present an overview of the company at 6:00pm ET (3:00pm PT) on Tuesday, January 8, 2002, from The Westin St. Francis Hotel in San Francisco, CA.

Alkermes is a leader in the development of products based on sophisticated drug delivery technologies. We have several areas of focus, including (i) controlled, sustained-release of injectable drugs lasting several days to several weeks, using our ProLease(R) and Medisorb(R) technologies and (ii) the development of pharmaceutical products based on our proprietary AIR(TM) pulmonary technology. In addition to our Cambridge, Massachusetts, headquarters, research and manufacturing facilities, Alkermes operates research and manufacturing facilities in Ohio and a medical affairs office in Cambridge, England.

CONTACT:          Rebecca Peterson
                  Director, Investor Relations
                  Alkermes, Inc.
                  (617) 583-6378

URL:              http://www.businesswire.com
Today's News On The Net - Business Wire's full file on the Internet
with Hyperlinks to your home page.

Copyright (C) 2002 Business Wire.  All rights reserved.